FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,048,708 | +11.1% | 911,871 | -17.4% | 0.00% | – |
Q2 2023 | $3,642,785 | +10.0% | 1,103,874 | -5.0% | 0.00% | – |
Q1 2023 | $3,312,749 | -61.2% | 1,162,368 | -1.0% | 0.00% | -100.0% |
Q4 2022 | $8,543,888 | -12.0% | 1,173,611 | -2.2% | 0.00% | 0.0% |
Q3 2022 | $9,711,000 | +68.1% | 1,200,302 | +1.8% | 0.00% | 0.0% |
Q2 2022 | $5,776,000 | -78.0% | 1,178,956 | +6.4% | 0.00% | -75.0% |
Q1 2022 | $26,215,000 | +1555.0% | 1,108,424 | +1137.8% | 0.00% | – |
Q4 2021 | $1,584,000 | -33.9% | 89,550 | +5.3% | 0.00% | – |
Q3 2021 | $2,398,000 | +216.8% | 85,011 | +17.6% | 0.00% | – |
Q2 2021 | $757,000 | -5.3% | 72,296 | +6.6% | 0.00% | – |
Q1 2021 | $799,000 | -31.0% | 67,805 | -31.4% | 0.00% | – |
Q4 2020 | $1,158,000 | +361.4% | 98,898 | +212.5% | 0.00% | – |
Q3 2020 | $251,000 | -66.6% | 31,649 | -22.9% | 0.00% | – |
Q2 2020 | $751,000 | +115.8% | 41,050 | +40.8% | 0.00% | – |
Q1 2020 | $348,000 | +54.0% | 29,148 | +114.1% | 0.00% | – |
Q4 2019 | $226,000 | +882.6% | 13,616 | +294.3% | 0.00% | – |
Q3 2019 | $23,000 | – | 3,453 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |